日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study

达雷妥尤单抗联合来那度胺作为新诊断多发性骨髓瘤移植后维持治疗：AURIGA 研究

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2024025746
Badros, Ashraf; Foster, Laahn; Anderson, Larry D Jr; Chaulagain, Chakra P; Pettijohn, Erin; Cowan, Andrew J; Costello, Caitlin; Larson, Sarah; Sborov, Douglas W; Shain, Kenneth H; Silbermann, Rebecca; Shah, Nina; Chung, Alfred; Krevvata, Maria; Pei, Huiling; Patel, Sharmila; Khare, Vipin; Cortoos, Annelore; Carson, Robin; Lin, Thomas S; Voorhees, Peter
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses

移植后新诊断的多发性骨髓瘤患者接受达雷妥尤单抗联合来那度胺维持治疗：AURIGA 亚组分析

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01355-0
Foster, Laahn; Anderson, Larry D Jr; Chung, Alfred; Chaulagain, Chakra P; Pettijohn, Erin; Cowan, Andrew J; Costello, Caitlin; Larson, Sarah; Sborov, Douglas W; Shain, Kenneth H; Silbermann, Rebecca; Voorhees, Peter; Krevvata, Maria; Pei, Huiling; Patel, Sharmila; Khare, Vipin; Cortoos, Annelore; Carson, Robin; Lin, Thomas S; Badros, Ashraf
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Letter to the Editor regarding 'Evaluating nurse preferences for a novel on-body delivery system vs. manual syringes for large-volume subcutaneous drug administration: a survey study'

致编辑的信，内容关于“评估护士对新型体表给药系统与手动注射器进行大容量皮下给药的偏好：一项调查研究”

期刊:Drug Delivery
影响因子:8.1
doi:10.1080/10717544.2025.2537813
Medhekar, Rohan; Clark, Laura; Gautam, Santosh; Cortoos, Annelore
发表日期：2025
文献求助 收藏

Energy and protein nutrition adequacy in general wards among intensive care unit survivors: A systematic review and meta-analysis

重症监护室幸存者在普通病房的能量和蛋白质营养充足性：系统评价和荟萃分析

期刊:Journal of Parenteral and Enteral Nutrition
影响因子:4.1
doi:10.1002/jpen.2699
Rosseel, Zenzi; Cortoos, Pieter-Jan; Leemans, Lynn; van Zanten, Arthur R H; Ligneel, Claudine; De Waele, Elisabeth
发表日期：2025
文献求助 收藏

A plain language summary of the final analysis of the GRIFFIN study of daratumumab plus lenalidomide, bortezomib, and dexamethasone for people with newly diagnosed multiple myeloma

GRIFFIN 研究最终分析的简明语言摘要，该研究评估了达雷妥尤单抗联合来那度胺、硼替佐米和地塞米松治疗新诊断多发性骨髓瘤患者的疗效。

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2024.2408909
Voorhees, Peter M; Sborov, Douglas W; Laubach, Jacob; Kaufman, Jonathan L; Reeves, Brandi; Rodriguez, Cesar; Silbermann, Rebecca; Costa, Luciano J; Anderson, Larry D Jr; Nathwani, Nitya; Shah, Nina; Bumma, Naresh; Efebera, Yvonne A; Holstein, Sarah A; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M; Orlowski, Robert Z; Shain, Kenneth H; Cowan, Andrew J; Dinner, Shira; Gries, Katharine S; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S; Usmani, Saad Z; Richardson, Paul G
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Community hematologist/oncologist perspectives on minimal residual disease testing in patients with multiple myeloma

社区血液科/肿瘤科医生对多发性骨髓瘤患者微小残留病灶检测的看法

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2546284
Gordan, Lucio N; Warner, Amanda; Heritage, Trevor; Ming, Amy; Gupta-Werner, Niodita; Kaila, Shuchita; Cortoos, Annelore
多发性骨髓瘤
肿瘤
肿瘤免疫
骨髓瘤
发表日期：2025
文献求助 收藏

Predictors of frontline doublet or triplet regimen initiation in transplant-ineligible newly diagnosed multiple myeloma

预测不适合移植的新诊断多发性骨髓瘤患者一线双药或三药方案启动的因素

期刊:Future Science OA
影响因子:2.1
doi:10.1080/20565623.2025.2528523
Pianko, Matthew J; Gupta-Werner, Niodita; Emond, Bruno; Lefebvre, Patrick; Lafeuille, Marie-Hélène; Cortoos, Annelore; Kaila, Shuchita
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk

达雷妥尤单抗四联疗法用于适合移植且新诊断为多发性骨髓瘤、具有高细胞遗传学风险的患者

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-024-01030-w
Callander, Natalie S; Silbermann, Rebecca; Kaufman, Jonathan L; Godby, Kelly N; Laubach, Jacob; Schmidt, Timothy M; Sborov, Douglas W; Medvedova, Eva; Reeves, Brandi; Dhakal, Binod; Rodriguez, Cesar; Chhabra, Saurabh; Chari, Ajai; Bal, Susan; Anderson, Larry D Jr; Dholaria, Bhagirathbhai R; Nathwani, Nitya; Hari, Parameswaran; Shah, Nina; Bumma, Naresh; Holstein, Sarah A; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M; Orlowski, Robert Z; Shain, Kenneth H; Cowan, Andrew J; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S; Giri, Smith; Costa, Luciano J; Usmani, Saad Z; Richardson, Paul G; Voorhees, Peter M
多发性骨髓瘤
细胞生物学
骨髓瘤
发表日期：2024
文献求助 收藏

Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN

在适合移植的新诊断多发性骨髓瘤患者中应用达雷妥尤单抗：GRIFFIN研究中具有临床意义的亚组的最终分析

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-024-01088-6
Chari, Ajai; Kaufman, Jonathan L; Laubach, Jacob; Sborov, Douglas W; Reeves, Brandi; Rodriguez, Cesar; Silbermann, Rebecca; Costa, Luciano J; Anderson, Larry D Jr; Nathwani, Nitya; Shah, Nina; Bumma, Naresh; Holstein, Sarah A; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M; Orlowski, Robert Z; Shain, Kenneth H; Cowan, Andrew J; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S; Voorhees, Peter M; Usmani, Saad Z; Richardson, Paul G
多发性骨髓瘤
骨髓瘤
发表日期：2024
文献求助 收藏

Case report: A case of severe capecitabine toxicity due to confirmed in trans compound heterozygosity of a common and rare DPYD variant

病例报告：一例因确诊的常见和罕见DPYD变异体的反式复合杂合性而导致严重卡培他滨毒性的病例

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1459565
de Haar-Holleman, Amy; Cortoos, Pieter-Jan; Vlaeminck, Jelle; Van Landuyt, Paulien; Steurbaut, Stephane; Vaeyens, Freya; Haufroid, Vincent
DPYD
毒理研究
发表日期：2024
文献求助 收藏